The IVD segments covered by Clearstate’s study included clinical chemistry, immunochemistry, haematology, coagulation, urinalysis, microbiology, critical care and molecular diagnostics. In 2008, this market experienced a rapid growth of ~14%. This market is set to continue with its rapid pace of growth of 10%-15% in the next few years, reaching an estimated USD 1.2 – 1.3 billion in 2010.
asia market insights
Greater China’s IVD market reached USD 990 million in 2008 with growth led by emerging market, China